503B Reporting: AERs

Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act

503B Adverse Event Reporting Guidance

503B Reporting: AERs

OMB: 0910-0800

Document [html]
Download: html







The system is under maintenance. It will be back shortly.

File Typetext/html
File Modified0000-00-00
File Created0000-00-00
© 2025 OMB.report | Privacy Policy